Attached files
| file | filename |
|---|---|
| 8-K - GENETHERA INC | form8k.htm |
Exhibit 16.1
January 30, 2015
Office of the Chief Accountant
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
We have read Item 4.01 included in the Form 8-K dated January 30, 2015 of GeneThera, Inc. to be filed with the Securities and Exchange Commission and are in agreement with the statements related to our firm.
Sincerely,
/s/: John Malone
MaloneBailey, LLP
Houston, Texas
www.malone-bailey.com